Olufunmilayo Olopade, MD, FACP, discusses the overhaul of precision oncology for true equity in cancer care, and brings focus to patient populations who have been understudied.
Anthony Lucci, MD, highlights the significant results of a study on the role of MRM in patients with de novo stage IV inflammatory breast cancer.
Adam Brufsky, MD, PhD, discusses evolving strategies in neoadjuvant/adjuvant treatment of early-stage TNBC.
At the annual Miami Breast Cancer Conference, Kelly Hunt, MD, discussed the use of neoadjuvant endocrine therapy for patients with breast cancer.
Anees Chagpar, MD, discusses her presentation on neoadjuvant chemo for cN0 breast cancer from the Miami Breast Cancer Conference.
Anees Chagpar, MD, highlights notable research and presentations from the annual Miami Breast Cancer Conference.
Dr Kalinsky discusses why gene profiling plays such an important role in the management of patients with early-stage breast cancer.
Aditya Bardia, MD, MPH, discusses the advancing therapy landscape for locally advanced, ER-positive breast cancer, and challenges associated with management of this disease.